| Name | 5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]-1,3-thiazolidine-2,4-dione |
|---|---|
| Synonyms |
5-({6-[(2-Fluorobenzyl)oxy]-2-naphthyl}methyl)-1,3-thiazolidine-2,4-dione
2,4-Thiazolidinedione, 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]- UNII-QOV2JZ647A Isaglitazone 5-({6-[(2-fluorobenzyl)oxy]naphthalen-2-yl}methyl)-1,3-thiazolidine-2,4-dione MCC-555 netoglitazone |
| Description | Netoglitazone is a dual agonist of PPARα and PPARγ with antihyperglycemic activity[1]. |
|---|---|
| Related Catalog | |
| Target |
PPARα PPARγ |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 599.5±30.0 °C at 760 mmHg |
| Molecular Formula | C21H16FNO3S |
| Molecular Weight | 381.420 |
| Flash Point | 316.4±24.6 °C |
| Exact Mass | 381.083496 |
| PSA | 80.70000 |
| LogP | 4.50 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.668 |
| Storage condition | 2-8°C |
| Symbol |
GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H410 |
| Precautionary Statements | P273-P501 |
| Hazard Codes | N |
| Risk Phrases | 50/53 |
| Safety Phrases | 60-61 |
| RIDADR | UN 3077 9 / PGIII |
| RTECS | XJ5813445 |
|
~65%
161600-01-7 |
| Literature: Mitsubishi Chemical Corporation Patent: US5594016 A1, 1997 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |